Parabolic Drugs

PARABDRUGS25 Jan 2021

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Parabolic Drugs

Parabolic Drugs

Pharmaceuticals

PARABDRUGS25 Jan 2021

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
14-Aug-2012	D	Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has recommend dividend @ Rs. 0.25 per share on fully paid equity shares of the Company for the year 2011-2012.	24-Sep-2012
16-Aug-2011	D	Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 20111, inter alia, has recommended dividend @ Rs. 0.50 per share on fully paid up equity shares of the Company for the year 2010-2011.	19-Sep-2011
04-Aug-2021	BC	Trading Members of the Exchange are hereby informed that pursuant to resolution plan approved by Hon'ble National Company Law Tribunal (NCLT), Chandigarh Bench vide its order dated January 12, 2021,	11-Aug-2021
04-Aug-2021	BC	Sub : Delisting -Parabolic Drugs Limited It is hereby notified that the following security shall be withdrawn (delisted) w.e.f. August 11, 2021. Symbol PARABDRUGS Company Name Parabolic Dr	11-Aug-2021
05-Feb-2021	BC	Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quar	11-Feb-2021
25-Jan-2021	BC	Resolution Plan -Extinguishment of equity anddelisting	29-Jan-2021
25-Jan-2021	BC	SUB. : - Resolution Plan - suspension of trading in equity shares of Parabolic Drugs Ltd (Scrip Code 533211). Trading members of the Exchange are hereby informed that, Parabolic Drugs Ltd has fi	28-Jan-2021

No Rights has been declared by PARABDRUGS

Book Closure

Record Date	Split Date	Purpose
11-Aug-2021	-	Trading Members of the Exchange are hereby informed that pursuant to resolution plan approved by Hon'ble National Company Law Tribunal (NCLT), Chandigarh Bench vide its order dated January 12, 2021,
11-Aug-2021	-	Sub : Delisting -Parabolic Drugs Limited It is hereby notified that the following security shall be withdrawn (delisted) w.e.f. August 11, 2021. Symbol PARABDRUGS Company Name Parabolic Dr
11-Feb-2021	-	Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quar
29-Jan-2021	-	Resolution Plan -Extinguishment of equity anddelisting
28-Jan-2021	-	SUB. : - Resolution Plan - suspension of trading in equity shares of Parabolic Drugs Ltd (Scrip Code 533211). Trading members of the Exchange are hereby informed that, Parabolic Drugs Ltd has fi

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Parabolic Drugs Ltd ₹5.70(0.00/0.00%)	5.70	+0.00	35.28	141.53	0.00	-0.04
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.23	0.27	0.00	0.00	0.00	0.00
Total Income	0.23	0.27	0.00	0.00	0.00	0.00
Total Expenditure	0.84	0.44	1.71	1.71	1.71	1.71
PBIDT	-0.61	-0.17	-1.71	-1.71	-1.71	-1.71
Interest	0.34	0.46	0.17	0.17	0.17	0.17
PBDT	-0.95	-0.63	-1.88	-1.88	-1.88	-1.88
Depreciation	5.10	4.85	5.34	5.34	5.34	5.34
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-6.05	-5.48	-7.22	-7.22	-7.22	-7.22
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-6.05	-5.48	-7.22	-7.22	-7.22	-7.22

EPS (Unit Curr.)	-0.98	-0.88	-1.17	-1.17	-1.17	-1.17
EPS (Adj) (Unit Curr.)	-0.98	-0.88	-1.17	-1.17	-1.17	-1.17
Calculated EPS (Unit Curr.)	-0.98	-0.89	-1.17	-1.17	-1.17	-1.17
Calculated EPS (Adj) (Unit Curr.)	-0.98	-0.89	-1.17	-1.17	-1.17	-1.17
Calculated EPS (Ann.) (Unit Curr.)	-3.91	-3.54	-4.67	-4.67	-4.67	-4.67
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-3.91	-3.54	-4.67	-4.67	-4.67	-4.67
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	61.89	61.89	61.89	61.89	61.89	61.89
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	61.89	61.89	61.89	61.89	61.89	61.89
Reserves Total	-934.22	-877.22	-769.15	-283.96	95.03	226.76
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	26.00	26.00	26.00	26.00	26.00	12.28
Total Shareholders Funds	-846.33	-789.33	-681.26	-196.07	182.92	300.93
Secured Loans	948.78	943.69	937.47	925.00	809.56	739.21
Unsecured Loans	35.33	35.78	34.28	32.49	32.38	37.93
Total Debt	984.11	979.47	971.75	957.49	841.94	777.14
Total Liabilities	137.78	190.14	290.49	761.42	1024.86	1078.07
APPLICATION OF FUNDS :
Gross Block	481.10	482.71	482.74	485.98	398.34	382.25
Less : Accumulated Depreciation	154.74	133.87	111.55	90.85	67.59	48.71
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	326.36	348.84	371.19	395.13	330.75	333.54
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	6.52	6.52	6.52	6.52	81.49	72.29
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	6.34	6.33	6.33	6.32	6.14	6.14
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	15.88	15.25	40.10	315.38	367.59	351.10
Sundry Debtors	28.82	66.96	70.06	98.05	148.98	138.59
Cash and Bank	0.78	0.60	0.64	3.02	5.99	12.09
Loans and Advances	32.04	33.75	35.40	34.43	43.77	99.94
Total Current Assets	77.53	116.56	146.20	450.89	566.32	601.72
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	245.42	269.08	255.11	160.80	199.59	158.28
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	245.42	269.08	255.11	160.80	199.59	158.28
Net Current Assets	-167.88	-152.51	-108.91	290.09	366.73	443.44
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	128.25	60.26
Deferred Tax Liability	34.70	32.94	29.89	25.46	23.38	16.70
Net Deferred Tax	-34.70	-32.94	-29.89	-25.46	104.87	43.56
Total Assets	136.65	176.23	245.24	672.60	889.98	898.97
Contingent Liabilities	0.00	0.00	0.00	85.20	91.83	30.38

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	61.89	61.89	61.89	61.89	61.89	61.89
Reserves Total	-943.24	-885.69	-777.60	-291.90	88.36	222.16
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	26.00	26.00	26.00	26.00	26.00	12.28
Total Shareholders Funds	-855.35	-797.80	-689.71	-204.01	176.25	296.33
Minority Interest	0.00	0.00	0.00	0.00	0.02	0.02
Secured Loans	948.78	943.69	938.89	926.72	811.55	744.28
Unsecured Loans	34.25	34.69	32.51	30.57	30.26	35.92
Total Debt	983.03	978.38	971.40	957.29	841.81	780.20
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	1.04	1.22	1.51	2.46	2.75	3.03
Total Liabilities	128.72	181.80	283.20	755.74	1020.83	1079.58
APPLICATION OF FUNDS :
Gross Block	480.44	482.04	483.52	486.04	398.40	382.30
Less: Accumulated Depreciation	154.07	133.20	112.32	90.89	67.60	48.71
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	326.37	348.84	371.20	395.15	330.80	333.59
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	6.52	6.52	6.52	6.52	81.97	72.92
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.14	0.13	0.13	0.12	0.07	0.07
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	15.88	15.25	40.36	315.93	368.07	351.75
Sundry Debtors	28.82	67.12	70.23	98.24	149.33	139.14
Cash and Bank	0.87	0.64	0.73	3.20	6.06	13.19
Loans and Advances	28.15	30.25	32.76	32.16	41.92	101.55
Total Current Assets	73.73	113.26	144.07	449.53	565.38	605.62
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	246.43	270.06	256.68	162.63	200.84	159.29
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	246.43	270.06	256.68	162.63	200.84	159.29
Net Current Assets	-172.70	-156.80	-112.61	286.90	364.54	446.33
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.92	0.92	0.92	0.92	129.17	61.18
Deferred Tax Liability	34.70	32.94	29.89	25.46	23.39	16.70
Net Deferred Tax	-33.78	-32.02	-28.97	-24.54	105.78	44.48
Other Assets	2.18	15.13	46.93	91.59	137.67	182.18
Total Assets
Contingent Liabilities	0.00	0.00	0.00	0.00	91.83	30.38

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash and Cash Equivalents at Beginning of the year	0.60	0.64	3.02	5.99	12.10
Net Cash from Operating Activities	3.02	1.65	89.58	-3.94	27.94
Net Cash Used In Investing Activities	0.86	0.50	1.39	-15.89	-29.99
Net Cash Used In Financing Activities	-3.70	-2.19	-93.36	16.87	-4.06
Net Inc./Dec In Cash And Cash Equivalents	0.18	-0.04	-2.39	-2.96	-6.11
Cash And Cash Equivalents At End Of The Year	0.78	0.60	0.64	3.02	5.99

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

37.79%

FII Shareholding

8.06%

DII Shareholding

0.57%

Public Shareholding

53.57%

**Promoter pledged shareholding 37.79%

About Parabolic Drugs Ltd

Parabolic Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 35.28 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -6.05 crores for the quarter ended December 2018. The company management includes , Pranav Gupta,Vineet Gupta,Jagjit Singh Chahal,Vandana Singla,Sanjeev Kumar (Parabolic Drugs Ltd) among others.

Chairman

Registered office

SCO 186-187 2nd Floor,Sector 8c,Chandigarh,Chandigarh,160008

FAX :

Background

Incorporation Year1996

Face Value₹10

Market Lot1

How to buy Parabolic Drugs shares on nse?

To buy Parabolic Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Parabolic Drugs share price today?

The Parabolic Drugs shares price on nse is Rs.5.7 today.

What is the market cap of Parabolic Drugs shares on BSE ?

The company has a market capitalization of Rs.35.28Cr

What is the PE & PB ratio of Parabolic Drugs shares ?

PE is 0 and PB is -0.04

What is the 52 Week High and Low of Parabolic Drugs shares?

Parabolic Drugs stock price high: Rs.5.7 Parabolic Drugs stock price low: Rs.0